TBI-166
| CAS No. | 1353734-12-9 | Cat. No. | BCP45029 |
| Name | TBI-166 | ||
| Synonyms | TBI166;TBI 166; | ||
| Formula | C32H30F3N5O3 | M. Wt | 589.62 |
| Description | TBI-166, derived from riminophenazine analogues, is under development in a phase I clinical trial in China. TBI-166 showed more potent anti-tuberculosis (anti-TB) activity than did clofazimine in in vitro and animal experiments. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antibiotic | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.